Pds Biotechnology (PDSB): Director bought ~$25K

~$25K

Approx. value · 15K sh @ $1.66

61K

Holds after · shares reported

Traded

Feb 28, 2025

Filed

Mar 3, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 28, 2025 · this disclosureInsiderDirector purchased ~$25K of PDSB shares in the open market

What came next

1. Feb 28, 2025InsiderDirector purchased ~$25K of PDSB shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Pds Biotechnology

For Pds Biotechnology, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PDSB page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Pds Biotechnology

• SEC Schedule 13DNov 12, 2026
• SEC Form 4Mar 3, 2025

Everything OQRO holds on this company is on its PDSB page.